Trastuzuma

DRUG2 trials

Sponsors

Fudan University, Peking University Cancer Hospital & Institute

Conditions

Gastric CancerHER2-positive Breast Cancer

Phase 2

Adjuvant Serplulimab and Trastuzuma and Chemotherapy in Her-2+ Gastric Cancer

RecruitingNCT05975749

Fudan UniversityGastric Cancer

Start: 2023-01-01End: 2029-01-01Target: 114Updated: 2024-03-12

Unknown Phase

Pyrotinib Combined With Trastuzumab and Pertuzumab for Maintenance Therapy in HER2-Positive Advanced Breast Cancer

Not yet recruitingNCT07470203

Peking University Cancer Hospital & InstituteHER2-positive Breast Cancer

Start: 2026-03-31End: 2029-09-30Target: 42Updated: 2026-03-13